Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.
Biofourmis has raised $20.0M in total funding. The most recent round was Series D. The last funding was announced in July 2022.
Biofourmis's investors include General Atlantic, Sequoia Capital, Peak XV Partners, CVS Health, Intel Capital.
Biofourmis is headquartered in Boston, United States.
Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.
Biofourmis is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biofourmis — Funding & Investors." VCBacked, July 27, 2022, https://www.vcbacked.co/company/biofourmis. Accessed November 12, 2026.
VCBacked. (2022). Biofourmis — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/biofourmis
{{cite web |title=Biofourmis — Funding & Investors |url=https://www.vcbacked.co/company/biofourmis |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Biofourmis? Request a listing update